landiolol and Sepsis
landiolol has been researched along with Sepsis in 8 studies
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bion, J; Boota, N; Gates, S; Ghuman, B; Gordon, AC; Hill, M; Hossain, A; Innes, R; Lall, R; Lord, J; MacCallum, NS; McAuley, D; Mistry, D; Perkins, GD; Regan, SE; Singer, M; Skilton, E; Veenith, T; Welters, I; Whitehouse, T; Yeung, J; Young, D | 1 |
| Kakihana, Y; Matsuda, N; Morimatsu, H; Morishima, E; Nagano, T; Nishida, O; Ogura, H; Okajima, M; Taniguchi, T; Yamada, Y | 1 |
| Morelli, A; Rehberg, S; Whitehouse, T | 1 |
| Bernard, M; Desrois, M; Fourny, N; Iché-Torres, M; Kober, F; Lalevée, N; Lan, C; Lê, LT; Leone, M; Mathieu, C; Mège, JL; Singer, M; Tran, TT | 1 |
| Hagiya, K; Islam, MM; Jesmin, S; Kamiyama, J; Kawano, S; Khatun, T; Mizutani, T; Oki, M; Rahman, MA; Sakuramoto, H; Seki, Y; Shimojo, N; Sonobe, A | 1 |
| Azuma, H; Oka, H; Sugimoto, M | 1 |
| Akhtar, S; Hideaki, S; Hizawa, N; Inoue, Y; Jesmin, S; Kawano, S; Khatun, T; Kiwamoto, T; Matsuishi, Y; Mizutani, T; Mowa, CN; Shimojo, N; Tsunoda, Y; Zaedi, S | 1 |
| Hongo, T; Ogawa, R; Sakamoto, A; Yoshida, Y | 1 |
Trials
1 trial(s) available for landiolol and Sepsis
| Article | Year |
|---|---|
Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Female; Humans; Male; Morpholines; Sepsis; Tachycardia; Treatment Outcome; Urea | 2020 |
Other Studies
7 other study(ies) available for landiolol and Sepsis
| Article | Year |
|---|---|
Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical Trial.
Topics: Adrenergic beta-Antagonists; Adult; Female; Humans; Male; Middle Aged; Norepinephrine; Sepsis; Shock, Septic; State Medicine; Tachycardia | 2023 |
β-blockade in sepsis: regulation of persisting sepsis-related tachycardia.
Topics: Humans; Morpholines; Sepsis; Tachycardia; Urea | 2020 |
Sex-Mediated Response to the Beta-Blocker Landiolol in Sepsis: An Experimental, Randomized Study.
Topics: Adrenergic beta-Antagonists; Animals; Female; Heart; Magnetic Resonance Imaging; Male; Morpholines; Rats; Rats, Wistar; Sepsis; Sex Factors; Stroke Volume; Treatment Outcome; Urea; Ventricular Function, Left | 2018 |
Significant reversal of cardiac upregulated endothelin-1 system in a rat model of sepsis by landiolol hydrochloride.
Topics: Animals; Blood Gas Analysis; Disease Models, Animal; Endothelin-1; Hemodynamics; Interleukin-6; Male; Morpholines; Myocardium; Rats, Wistar; Receptors, Endothelin; Sepsis; Tumor Necrosis Factor-alpha; Ultrasonography; Up-Regulation; Urea | 2014 |
Efficacy of landiolol for the treatment of junctional ectopic tachycardia resulting from sepsis.
Topics: Anti-Arrhythmia Agents; Child, Preschool; Female; Humans; Morpholines; Sepsis; Tachycardia, Ectopic Junctional; Treatment Outcome; Urea | 2016 |
Landiolol hydrochloride ameliorates acute lung injury in a rat model of early sepsis through the suppression of elevated levels of pulmonary endothelin-1.
Topics: Acute Lung Injury; Adrenergic beta-Antagonists; Animals; Down-Regulation; Endothelin-1; Lung; Male; Morpholines; Rats, Wistar; RNA, Messenger; Sepsis; Tumor Necrosis Factor-alpha; Urea | 2016 |
Successful management of tachycardiac atrial fibrillation in a septic patient with landiolol.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Hemodynamics; Humans; Intraoperative Complications; Laparoscopy; Male; Morpholines; Peritonitis; Sepsis; Tachycardia; Urea | 2005 |